Skip to content

Eurordis - Rare Disease Europe

About Us

Our Governance

Our Network

Rare Disease Policy

Priority Areas

Cross-cutting Areas

About Rare Diseases

About Medicines For Rare Diseases

Find Support

With EURORDIS

Join Our Activities

Attend Our Events

[wpdreams_ajaxsearchlite]
Newsroom
Multimedia
Events
Members
Resources
Contact us
Accessibility Options
Donate

EURORDIS Round Table of Companies (ERTC)

36th Workshop of the EURORDIS Round Table of Companies (ERTC)36th Workshop of the EURORDIS Round Table of Companies (ERTC)July 2023Read More
35th Workshop of the EURORDIS Round Table of Companies (ERTC)35th Workshop of the EURORDIS Round Table of Companies (ERTC)January 2023Read More
ERTC Code of ConductERTC Code of ConductJuly 2022Download
33rd EURORDIS Round Table of Companies Workshop33rd EURORDIS Round Table of Companies WorkshopMay 2022Read More
32nd EURORDIS Round Table of Companies Workshop32nd EURORDIS Round Table of Companies WorkshopOctober 2021Read More
31st EURORDIS Round Table of Companies Workshop31st EURORDIS Round Table of Companies WorkshopMarch 2021Read More
30th EURORDIS Round Table of Companies Workshop30th EURORDIS Round Table of Companies WorkshopJuly 2020Read More
29th EURORDIS Round Table of Companies Workshop29th EURORDIS Round Table of Companies WorkshopDecember 2019Read More
28th EURORDIS Round Table of Companies Workshop28th EURORDIS Round Table of Companies WorkshopJune 2019Read More
3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease Therapies3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease TherapiesFebruary 2019Read More
27th EURORDIS Round Table of Companies Workshop27th EURORDIS Round Table of Companies WorkshopApril 2018Read More
26th EURORDIS Round Table of Companies Workshop26th EURORDIS Round Table of Companies WorkshopDecember 2017Read More
25th EURORDIS Round Table of Companies Workshop25th EURORDIS Round Table of Companies WorkshopAugust 2017Read More
2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease TherapiesOctober 2016Read More
24th Workshop of the EURORDIS Round Table of Companies: “Bringing solutions to young rare disease patients”24th Workshop of the EURORDIS Round Table of Companies: “Bringing solutions to young rare disease patients”July 2016Read More
1st Multi-stakeholder Symposium on Improving Patient Access to Rare Disease Therapies1st Multi-stakeholder Symposium on Improving Patient Access to Rare Disease TherapiesDecember 2015Read More
23rd Workshop, Barcelona: “Patient Relevant Outcome Measures & Patient Reported Outcomes”23rd Workshop, Barcelona: “Patient Relevant Outcome Measures & Patient Reported Outcomes”July 2015Read More
22nd Workshop, Brussels: “Rare Diseases: Going Global”22nd Workshop, Brussels: “Rare Diseases: Going Global”January 2015Read More
21st Workshop, Barcelona: “Sharing Rare Disease Patient Data: Translating Principles into Action”21st Workshop, Barcelona: “Sharing Rare Disease Patient Data: Translating Principles into Action”June 2014Read More
20th ERTC Workshop, Brussels: “Unlocking Europe’s Potential in Rare Disease Therapies”20th ERTC Workshop, Brussels: “Unlocking Europe’s Potential in Rare Disease Therapies”January 2014Read More
19th Workshop, Barcelona: “Practical aspects of progressive patient access to OMPs, post-marketing evidence generation and related pricing questions”19th Workshop, Barcelona: “Practical aspects of progressive patient access to OMPs, post-marketing evidence generation and related pricing questions”August 2013Read More
15th Workshop, Paris: “Compassionate Access to Rare Disease Therapies”15th Workshop, Paris: “Compassionate Access to Rare Disease Therapies”March 2013Read More
17th Workshop, Barcelona: “The Value of Orphan Drugs: Efficient for the Patients, Useful to Society?”17th Workshop, Barcelona: “The Value of Orphan Drugs: Efficient for the Patients, Useful to Society?”March 2013Read More
16th Workshop, Brussels: “The Value of Partnering in Rare Disease Therapies”16th Workshop, Brussels: “The Value of Partnering in Rare Disease Therapies”March 2013Read More
18th Workshop, Brussels: “Corporate Responsibility in Improving Access to Orphan Medicinal Products”March 2013Read More
13th Workshop, Paris: “Patients’ Access to OMPs, Innovative Pricing Schemes and National Measures in a Global Financial and Economic Crisis Environment”March 2013Read More
14th Workshop, Barcelona: “Mechanisms for the Implementation of the Clinical Added-Value (Relative Effectiveness) of Orphan Drugs, CAVOD”March 2013Read More
12th Workshop, Barcelona: “Retooling the EU Orphan Drug Regulation and US Orphan Drug Act for Better and Faster Development of Rare Disease Therapies”March 2013Read More
10th Workshop, Barcelona: “EURORDIS Strategy 2010-2015 and Partnership with the ERTC Members”March 2013Read More
11th Workshop, Paris: “Improving Access to Orphan Drugs for all Patients affected by Rare Diseases in Europe: EU Assessment of Clinical Added-Value of Orphan Drugs (CAVOD)”March 2013Read More
8th Workshop, Barcelona: “Impact of the EU Paediatric Regulation on Orphan Drug Development”March 2013Read More
7th Workshop, Paris: “Proof of Concept and Level of Evidence in Orphan Drug Development”March 2013Read More
5th Workshop, Paris: “Rare Disease Patient Registries: an Essential Tool in the Development of Therapies?”March 2013Read More
1st Workshop, Barcelona: “Compassionate Access Programmes for Orphan Drugs in Europe: from Heterogeneity to Harmonised Practices?”March 2013Read More
9th Workshop, Paris: “Significant Benefit of Orphan Drugs:Impact on Clinical Development and Assessment”December 2008Read More
6th Workshop, Barcelona: “Do Rare Disease Patients Have Real Access to Orphan Drugs in Europe?”June 2007Read More
4th Workshop, Barcelona: “Common Drugs for Common Needs:the US vs EU Approach to OMP Development”June 2006Read More
3rd Workshop, Barcelona: “Rare Disease Clinical Trials: Ensuring Fruitful Collaborations between Sponsors & Patient Organisations”November 2005Read More
2nd Workshop, Paris: “New Methodologies for Clinical Trials in Small Populations”July 2005Read More